Broad Modulation of Core Tau Biomarkers, Including P-Tau205, Following Lecanemab Treatment Supports Disease Modification Beyond Amyloid
Copies of these presentations obtained through the QR code are for personal use only and may not be used without permission from AAIC and the authors of this presentation.
